R&D Systems™ Recombinant Human B7-H3 Fc Chimera Biotinylated Protein, CF
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems™ BT1027050
DescriptionMeasured by its ability to inhibit anti-CD3-induced proliferation of stimulated human T cells. The ED50 for this effect is 3-12 μg/mL.
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.|
|Mouse myeloma cell line, NS0-derived human B7-H3 protein Human B7-H3 (Leu29-Pro245) (N-terminus) Accession # NP_079516 DIEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)|
|<0.10 EU / 1 µg of the protein by the LAL method.|
|Lyophilized from a 0.2 µm filtered solution in PBS with Trehalose|
|Lyophilized from a 0.2 µm filtered solution in PBS with Trehalose.|
|M.W. (Observed): 66-75 kDa, reducing conditions; M.W. (theoretical): 50 kDa (unlabeled)|
|12 months from date of receipt, <= -20 °C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution.|
|Reconstitute at 200 µg/mL in PBS.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok